Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EFFECTS OF EXTRACORPOREAL CYTOKINE ELIMINATION ON HEMODYNAMIA AND MORTALITY IN CRITICAL PATIENTS

NCT05984407 is registered in ClinicalTrials.gov with Hakan Küçükkepeci as lead sponsor.

NCT NCT05984407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05984407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EFFECTS OF EXTRACORPOREAL CYTOKINE ELIMINATION ON HEMODYNAMIA AND MORTALITY IN CRITICAL PATIENTS
Lead sponsor
Hakan Küçükkepeci
Phase
Observational
Overall status
Unknown status
Start date
August 1, 2023
Completion date
February 1, 2024
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cytokine hemadsorption therapy in critically ill patients who have no microbiological findings and develop vasoplegic shock